b'Appendices Appendix 3Financial ManagementG enome Canada has invested $3.6 billion inAll research projects, with few exceptions, require genomics research since its creation in 2000.co-funding from other parties, including provincial The federal government provided $1.5 billion,governments, universities, the private sector, and including investment income from this funding. Theothernationalandinternationalorganizations. remaining $2.1 billion came from national and inter- Genome Canadas funding ratio for co-funding was national partners, including provincial governments,1:1 prior to 2012. However, it has since increased to andprivateandpublicsectorpartners.Genomeapproximately 1:1.6.Canadas investments support large-scale science, access to leading-edge technology, translation, andGenome Canada receives funding each year from the operations of Genome Canada and the six re- the federal government based on the annual re-gional Genome Centres.quirements of research projects. This funding goes to the six Genome Centres, which direct the funds to the individual projects located in their regions. In addition, the projects, administered at institu-tions, receive funding directly from the required Investment by Genome Canada co-funders. The Centres and project leaders must and Partners from 2000-19 report co-funding quarterly to Genome Canada. The total annual financial investment in projects is 12% shown in the graph below. Genome Canada and the Centres monitor total project investment. Genome Canada project leaders managed $182.3 million in funding in 2018-19, comprised of $62 million from Genome Canada and $120.3 million from co-funding. 19% 41%Genome Canadas operating costs were $6.1 million in 2018-19. Operations include activities relating to genomics programs, strategy, fundraising, commu-nications, governance, performance and evaluation, 20% 8% genomics in society and administration. Genome Canadas operating costs include the fol- Genome Canada 41%Provincial 20% lowing statement of remuneration. The Board and committee members do not receive remunerationIndustry 12%Federal 8% for their services; however, Genome Canada pays theNPO/Other 19% expenses incurred by directors in the performance of their duties. For staff of Genome Canada, there is a Total Genome Canada funding = $1.5 billion compensation policy that includes job classifications Total co-funding = $2.2 billion and related salary ranges. Genome Canada employ-ees are eligible for performance awards from 10 toTotal investment = $3.7 billion 25 per cent.Genome Canada Annual Report 2018-19 45'